Shiver
Conditions
Interventions
C:iv 0.9%NS 4ml
O:iv ondansetron 8mg
N:iv nalbuphine 0.04mg/kg
Sponsors
Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University Shanghai
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: (1) ASA grade I to II; (2) Aged 20-45 years old; (3) 150-180cm height; (4) 60-100kg weight; (5) Indices of cardiac, liver, kidney, blood and other examinations are in the normal range; (6) Full-term singleton pregnancies; (7) According to GCP, all volunteers sign the informed consent.
Exclusion criteria
Exclusion criteria: The exclusion criteria were as follows: contraindications to neuraxial anaesthesia, allergy to a study drug, body mass index (BMI) >35 kg m-2, pregnancy-induced hypertension, impaired renal or hepatic function, thyroid disease, neuromuscular disease, vasodilator use, body temperature >38 °C or <36.5 °C, prior labour analgesia and refusal to participate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of post-anaesthesia maternal shivering before delivery; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence and severity of maternal shivering after spinal anaesthesia;APGAR score;Haemodynamics;tympanic membrane temperature;Sedation scores; | — |
Countries
China
Contacts
Public ContactShaoqiang Huang
Department of Anesthesiology, Obstetrics and Gynecology Hospital of Fudan University Shanghai
Outcome results
None listed